Medical device maker Misonix Inc. closed its acquisition of Virginia-based Solsys Medical LLC in an all-stock transaction valued about $109 million.
New York-based Misonix acquired Solsys by issuing about 5.7 million new shares to former unitholders of the wound care company. Also, Misonix assumed Solsys' outstanding secured debt of about $24 million.
Misonix shareholders now own about 64% of the combined entity, and former Solsys unitholders own the remaining 36%.
The deal adds Solsys' wound treatment TheraSkin to Misonix's product portfolio, which includes wound debridement solution SonicOne.
